In the published article, there was an error in the Funding statement.
The author(s) declare that financial support was received for the research and/or publication of this article. This work was supported by grant from the Ministry of health, Czech Republic for the Conceptual Development of a Research Organization (FNOL, 0098892); IGA_LF_2024_021 and project “New Technologies for Digital Health” (Reg. No. CZ.02.01.01/00/23_021/0008829) from the Operational Programme Jan Ámos Komenský financed by the European Union (EU) and the State Budget of Czech Republic (AZV Grant No. NW25-04-00194).
The correct Funding statement appears below.
Statements
Funding
The author(s) declare that financial support was received for the research and/or publication of this article. This work was supported by grant from the Ministry of health, Czech Republic for the Conceptual Development of a Research Organization (FNOL, 0098892); IGA_LF_2024_021 and project “New Technologies for Digital Health” (Reg. No. CZ.02.01.01/00/23_021/0008829) from the Operational Programme Jan Ámos Komenský financed by the European Union (EU) and the State Budget of Czech Republic; and AZV grant financed by the State Budget of Czech Republic (AZV Grant No. NW25-04-00194).
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
alpha-synuclein, seed amplification assays, RT-QuIC, Parkinson's disease, biomarkers
Citation
Koníčková D, Hraboš D, Menšíková K, Tučková L, Kaleta M, Strnad M, Colosimo C and Kaňovský P (2025) Correction: RT-QuIC: a highly promising diagnostic method for neurodegenerative diseases—advantages and limitations. Front. Neurol. 16:1636086. doi: 10.3389/fneur.2025.1636086
Received
27 May 2025
Accepted
29 May 2025
Published
09 June 2025
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
16 - 2025
Updates
Copyright
© 2025 Koníčková, Hraboš, Menšíková, Tučková, Kaleta, Strnad, Colosimo and Kaňovský.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: D. Koníčková dorota.konickova@upol.cz
†ORCID: D. Koníčková orcid.org/0000-0003-4446-0060
D. Hraboš orcid.org/0000-0001-9856-0126
K. Menšíková orcid.org/0000-0003-4834-3160
L. Tučková orcid.org/0000-0002-5976-7535
M. Kaleta orcid.org/0000-0003-0875-2912
M. Strnad orcid.org/0000-0002-2806-794X
C. Colosimo orcid.org/0000-0002-2216-3973
P. Kaňovský orcid.org/0000-0002-9009-3241
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.